Sanofi Genzyme Competitors and Similar CompaniesClear all

Amgen's competitors and similar companies include Amicus Therapeutics.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
1980
Founding Date
2002
Type
Type
Public
Type
Public
Tags
Locations
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Employees
Employees
25,200
Employees
58415% increase
Valuation ($)
Valuation ($)
170.4 b
Valuation ($)
3.4 b

Financial

Revenue (est.)
Revenue (est.)
$36.8b (FY, 2025)
Revenue (est.)
$634.2m (FY, 2025)
Cost of goods
Cost of goods
$12b (FY, 2025)
Cost of goods
$72.9m (FY, 2025)
Gross profit
Gross profit
$24.7b (FY, 2025)
Gross profit
$561.3m (FY, 2025)
Net income
Net income
$7.7b (FY, 2025)
Net income
($27.1m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company